Position in MGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$227,939
-$153,060 QoQ
Shares Held
170,104
-27.7% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. MGX ranks #321 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in MGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,939 | 170,104 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $380,999 | 235,185 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $736,340 | 310,692 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $566,888 | 383,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $251,746 | 185,108 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $52,016 | 14,409 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $906,795 | 417,878 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,277,700 | 313,162 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,886,631 | 747,548 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||